Biotoxtech Co., Ltd. (KOSDAQ:086040)
South Korea
· Delayed Price · Currency is KRW 2,910.00
+30.00 (1.04%)
At close: Apr 1, 2025, 3:30 PM KST
Biotoxtech Revenue
In the year 2024, Biotoxtech had annual revenue of 41.34B KRW with 26.69% growth. Biotoxtech had revenue of 11.42B in the quarter ending December 31, 2024, with 33.99% growth.
Revenue
41.34B
Revenue Growth
+26.69%
P/S Ratio
1.11
Revenue / Employee
208.80M
Employees
198
Market Cap
45.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.34B | 8.71B | 26.69% |
| Dec 31, 2023 | 32.63B | -4.66B | -12.50% |
| Dec 31, 2022 | 37.29B | 4.57B | 13.98% |
| Dec 31, 2021 | 32.72B | 6.29B | 23.80% |
| Dec 31, 2020 | 26.43B | 574.78M | 2.22% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |